GlassScriptPhysician profile
Andrew J Boyle
NPI 1992741128
$10,634.22
in general payments reported to CMS, 2019-2025
15 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,214 · 2020: $654 · 2021: $392 · 2022: $1,757 · 2023: $1,058 · 2024: $1,313 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,897 · Travel and Lodging: $1,590 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,897.24 |
| Travel and Lodging | $1,590.46 |
| Education | $129.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,024.29 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Abiomed | $2,424.15 | 2019-2025 | Impella |
| Cvrx, INC. | $448.27 | 2019-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $293.80 | 2019-2021 | |
| Novo Nordisk INC | $150.50 | 2024 | Wegovy |
| Boston Scientific Corporation | $121.24 | 2023 | Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $42.88 | 2023-2025 | |
| W. L. Gore & Associates, INC. | $33.63 | 2022 | |
| Edwards Lifesciences Corporation | $25.45 | 2023 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.42 | 2020 | |
| Medtronic, INC. | $19.05 | 2021 | |
| Haemonetics Corporation | $17.46 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.08 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Boyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.